Peptides are supplied as a lyophilised powder because water is what enables most of the degradation pathways that matter. Freeze-drying removes it, which is why a sealed vial of powder tolerates conditions that a solution would not.
Why ambient shipping is usually acceptable
A great deal of confusion in this category comes from applying cold-chain expectations to a material that does not require them in transit. Lyophilised peptide in a sealed vial is generally stable at ambient temperature over the days a shipment takes. Suppliers who ship with a gel pack in summer are managing the upper end of that range rather than maintaining a cold chain.
Where transit duration genuinely matters is at the extremes. A parcel held for two weeks in customs in mid-summer is a different exposure from a two-day domestic shipment, which is one practical reason sourcing domestically reduces variability.
Storage before reconstitution
Sealed lyophilised powder is typically stored refrigerated for medium-term holding, or frozen for longer periods. The variable that does the damage is not temperature alone but moisture ingress, which is why vials are brought to room temperature before opening. Opening a cold vial invites condensation onto the powder, reintroducing exactly the water the lyophilisation removed.
After reconstitution
Once in solution the stability picture changes completely. Solutions are held refrigerated and have a far shorter usable window than the sealed powder did. Repeated freeze-thaw cycling is the other common source of loss, and it is avoidable by aliquoting into single-use volumes at the point of reconstitution rather than returning the stock vial to the freezer repeatedly.
Light and container material
Several compounds are light sensitive, which is why amber vials and opaque secondary packaging are used. Adsorption to container surfaces is a real effect at low concentrations and is one reason working solutions are usually prepared fresh rather than stored dilute.
Practical handling notes
- Bring vials to room temperature before opening to avoid condensation
- Reconstitute with the solvent stated on the certificate of analysis
- Aliquot into single-use volumes rather than refreezing the stock
- Keep light-sensitive material in its original amber container
- Record lot numbers against experiments so results stay traceable
None of this is exotic laboratory practice. It is ordinary sample handling, and it is the difference between a result that reproduces and one that does not.
Questions and answers
Do lyophilised research peptides need cold-chain shipping?
Generally no. Lyophilised peptide in a sealed vial is stable at ambient temperature over the days a shipment takes, and suppliers shipping with a gel pack in summer are managing the upper end of that range rather than maintaining a cold chain. Transit duration matters at the extremes: a parcel held two weeks in customs in midsummer is a different exposure from a two-day domestic shipment.
Why should a vial reach room temperature before it is opened?
Because the variable that does the damage is moisture ingress rather than temperature alone. Opening a cold vial invites condensation onto the powder, reintroducing exactly the water that lyophilisation removed.
How does the storage picture change after reconstitution?
Completely. Solutions are held refrigerated and have a far shorter usable window than the sealed powder did. Repeated freeze-thaw cycling is the other common source of loss, and it is avoidable by aliquoting into single-use volumes at the point of reconstitution rather than returning the stock vial to the freezer repeatedly.
Why are amber vials used for some compounds?
Several compounds are light sensitive, which is why amber vials and opaque secondary packaging are used. Adsorption to container surfaces is also a real effect at low concentrations, and is one reason working solutions are usually prepared fresh rather than stored dilute.